BCAP31 and synucleinopathy: BAP31 deficiency exacerbates α-synucleinopathy-associated neurodegeneration by disrupting mitochondrial fission–fusion dynamics, impairing PINK1–Parkin-mediated, amplifying dopaminergic neuron loss.